Health care automation startup Olive AI intends to sell a significant portion of its products and services to sibling company Rotera, per current and former employees and documents seen by Axios.
Why it matters: Once considered the darling of health system automation, Olive's had a difficult year amid questions about its software's efficacy and executive departures. The divest to Rotera would effectively eliminate Olive's health systems product line, which represents 15-30% of its overall business.
